Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass

Journal of Muscle Research and Cell Motility

Volumn 30, Issue 7-8, 2009, Pages 243-253

  Cassano, Marco ^a   Quattrocelli, Mattia ^a   Crippa, Stefania ^a   Perini, Ilaria ^a   Ronzoni, Flavio ^a,b   Sampaolesi, Maurilio ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

AKT; Magic F1; Muscle hypertrophy

Indexed keywords

MYOSTATIN; SOMATOMEDIN;

ANIMAL; ATROPHY; CACHEXIA; CELL; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; HUMAN; HYPERTROPHY; METABOLISM; MUSCLE; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MUSCLE DISEASE; MUSCULOSKELETAL SYSTEM; MYOBLAST; PATHOLOGY; PHYSIOLOGY; REGENERATION; REVIEW; SKELETAL MUSCLE;

ANIMALS; ATROPHY; CACHEXIA; CELL DIFFERENTIATION; CELLS; GENE EXPRESSION REGULATION; HUMANS; HYPERTROPHY; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUSCLES; MUSCULAR ATROPHY; MUSCULAR DISEASES; MUSCULOSKELETAL SYSTEM; MYOBLASTS; MYOSTATIN; REGENERATION; SOMATOMEDINS;

MAMMALIA;

EID: 77951022683     PISSN: 01424319     EISSN: 15732657     Source Type: Journal    
DOI: 10.1007/s10974-010-9204-y     Document Type: Review

References (133)

1. Acharyya S, Butchbach ME et al (2005) Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell 8(5):421-432 (Pubitemid 41579836)
2. Adams GR, McCue SA (1998) Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol 84(5):1716-1722
3. Adams GR, Caiozzo VJ et al (2002) Cellular and molecular responses to increased skeletal muscle loading after irradiation. Am J Physiol Cell Physiol 283(4):C1182-C1195
4. Adams GR, Caiozzo VJ et al (2003) Skeletal muscle unweighting: spaceflight and ground-based models. J Appl Physiol 95(6): 2185-2201
5. Adi S, Bin-Abbas B et al (2002) Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation. Endocrinology 143(2):511-516 (Pubitemid 34107204)
6. Allen RE, Boxhorn LK (1989) Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor I, and fibroblast growth factor. J Cell Physiol 138(2):311-315 (Pubitemid 19061212)
7. Allen RE, Sheehan SM et al (1995) Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro. J Cell Physiol 165(2):307-312
8. Amthor H, Christ B et al (2002) Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth. Dev Biol 243(1):115-127 (Pubitemid 34208407)
9. Amthor H, Otto A et al (2006) Myostatin imposes reversible quiescence on embryonic muscle precursors. Dev Dyn 235(3): 672-680
10. Artaza JN, Bhasin S et al (2005) Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. Endocrinology 146(8):3547-3557 (Pubitemid 41058126)
11. Aziz MH, Kumar R et al (2003) Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int J Oncol 23(1):17-28
12. Bamman MM, Shipp JR et al (2001) Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans. Am J Physiol Endocrinol Metab 280(3):E383-E390 (Pubitemid 32466133)
13. Baracos VE (2001) Management of muscle wasting in cancerassociated cachexia: understanding gained from experimental studies. Cancer 92(6 Suppl):1669-1677
14. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281-297
15. Barton-Davis ER, Shoturma DI et al (1999) Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol Scand 167(4):301-305
16. Beauchamp JR, Heslop L et al (2000) Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 151(6):1221-1234
17. Bodine SC, Latres E et al (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294(5547):1704-1708 (Pubitemid 33104839)
18. Bogdanovich S, Krag TO et al (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420(6914): 418-421 (Pubitemid 35415652)
19. Bogdanovich S, Perkins KJ et al (2005) Myostatin propeptidemediated amelioration of dystrophic pathophysiology. Faseb J 19(6):543-549 (Pubitemid 40471245)
20. Brunet A, Sweeney LB et al (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303(5666):2011-2015 (Pubitemid 38393275)
21. Buckingham M (2001) Skeletal muscle formation in vertebrates. Curr Opin Genet Dev 11(4):440-448 (Pubitemid 32614204)
22. Cassano M, Biressi S et al (2008) Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis. PLoS One 3(9):e3223
23. Chakravarthy MV, Davis BS et al (2000) IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle. J Appl Physiol 89(4):1365-1379
24. Charlier C, Coppieters W et al (1995) The mh gene causing doublemuscling in cattle maps to bovine Chromosome 2. Mamm Genome 6(11):788-792
25. Clarke BA, Drujan D et al (2007) The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab 6(5):376-385 (Pubitemid 350011998)
26. Clop A, Marcq F et al (2006) A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38(7):813-818 (Pubitemid 43980603)
27. Coleman ME, DeMayo F et al (1995) Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 270(20):12109-12116
28. Conboy IM, Rando TA (2002) The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev Cell 3(3):397-409
29. Conboy IM, Conboy MJ et al (2003) Notch-mediated restoration of regenerative potential to aged muscle. Science 302(5650):1575-1577
30. Coulton GR, Curtin NA et al (1988a) The mdx mouse skeletal muscle myopathy: II. Contractile properties. Neuropathol Appl Neurobiol 14(4):299-314
31. Coulton GR, Morgan JE et al (1988b) The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol 14(1):53-70
32. Crisa A, Marchitelli C et al (2003) Sequence analysis of myostatin promoter in cattle. Cytogenet Genome Res 102(1-4):48-52 (Pubitemid 38280873)
33. DeVol DL, Rotwein P (1990) Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth. Am J Physiol 259(1 Pt 1):E89-E95 (Pubitemid 20229551)
34. Dhawan J, Rando TA (2005) Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol 15(12):666-673 (Pubitemid 41713968)
35. Di Giovanni S, Molon A et al (2004) Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol 55(2):195-206 (Pubitemid 38166996)
36. Doumit ME, Cook DR et al (1996) Testosterone up-regulates androgen receptors and decreases differentiation of porcine myogenic satellite cells in vitro. Endocrinology 137(4):1385-1394
37. Ebisawa T, Fukuchi M et al (2001) Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem 276(16):12477-12480 (Pubitemid 37385151)
38. Fiaccavento R, Carotenuto F et al (2005) Stem cell activation sustains hereditary hypertrophy in hamster cardiomyopathy. J Pathol 205(3):397-407 (Pubitemid 40253929)
39. Fiorotto ML, Schwartz RJ et al (2003) Persistent IGF-I overexpression in skeletal muscle transiently enhances DNA accretion and growth. Faseb J 17(1):59-60
40. Forte G, Minieri M et al (2006) Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells 24(1):23-33
41. Galvez BG, Sampaolesi M et al (2006) Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J Cell Biol 174(2):231-243 (Pubitemid 44079858)
42. Gargioli C, Coletta M et al (2008) PlGF-MMP-9-expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle. Nat Med 14(9):973-978
43. Gomes MD, Lecker SH et al (2001) Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 98(25):14440-14445
44. Greer EL, Brunet A (2005) FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24(50):7410-7425 (Pubitemid 41637981)
45. Guttridge DC, Mayo MW et al (2000) NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289(5488):2363-2366
46. Haddad F, Adams GR (2002) Selected contribution: acute cellular and molecular responses to resistance exercise. J Appl Physiol 93(1):394-403 (Pubitemid 34686237)
47. Haddad F, Adams GR (2004) Inhibition of MAP/ERK kinase prevents IGF-I-induced hypertrophy in rat muscles. J Appl Physiol 96(1):203-210 (Pubitemid 38032002)
48. Hameed M, Lange KH et al (2004) The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. J Physiol 555(Pt 1):231-240 (Pubitemid 38313073)
49. Hannan KM, Thomas G et al (2003) Activation of S6K1 (p70 ribosomal protein S6 kinase 1) requires an initial calciumdependent priming event involving formation of a high-molecular- mass signalling complex. Biochem J 370(Pt 2):469-477 (Pubitemid 36315135)
50. Hardt SE, Sadoshima J (2002) Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ Res 90(10):1055-1063 (Pubitemid 34627903)
51. Heslop L, Morgan JE et al (2000) Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J Cell Sci 113(Pt 12): 2299-2308 (Pubitemid 30426843)
52. Hill M, Goldspink G (2003) Expression and splicing of the insulinlike growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage. J Physiol 549(Pt 2):409-418
53. Hill JJ, Qiu Y et al (2003) Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. Mol Endocrinol 17(6):1144-1154
54. Horsley V, Jansen KM et al (2003) IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113(4):483-494
55. Hribal ML, Nakae J et al (2003) Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. J Cell Biol 162(4):535-541
56. Huang J, Forsberg NE (1998) Role of calpain in skeletal-muscle protein degradation. Proc Natl Acad Sci USA 95(21):12100-12105
57. Husmann I, Soulet L et al (1996) Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev 7(3):249-258
58. Iemura S, Yamamoto TS et al (1998) Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci USA 95(16):9337-9342
59. Joulia D, Bernardi H et al (2003) Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res 286(2):263-275
60. Kamei Y, Miura S et al (2004) Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem 279(39):41114-41123
61. Langenbach KJ, Rando TA (2002) Inhibition of dystroglycan binding to laminin disrupts the PI3 K/AKT pathway and survival signaling in muscle cells. Muscle Nerve 26(5):644-653
62. Langley B, Thomas M et al (2002) Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 277(51):49831-49840
63. Lapidos KA, Kakkar R et al (2004) The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res 94(8):1023-1031
64. Latres E, Amini AR et al (2005) Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3 K/ Akt/mTOR) pathway. J Biol Chem 280(4):2737-2744
65. Lecker SH, Solomon V et al (1999) Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. J Clin Invest 104(10):1411-1420
66. Lee SJ, McPherron AC (2001) Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98(16):9306-9311
67. Lee CT, Risom T et al (2007) Evolutionary conservation of microRNA regulatory circuits: an examination of microRNA gene complexity and conserved microRNA-target interactions through metazoan phylogeny. DNA Cell Biol 26(4):209-218
68. Li YP, Reid MB (2001) Effect of tumor necrosis factor-alpha on skeletal muscle metabolism. Curr Opin Rheumatol 13(6):483-487
69. Li YP, Lecker SH et al (2003) TNF-alpha increases ubiquitinconjugating activity in skeletal muscle by up-regulating UbcH2/ E220k. FASEB J 17(9):1048-1057
70. Li Y, Takemura G et al (2003) Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice. Circulation 107(19):2499-2506
71. Li ZF, Shelton GD et al (2005) Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality. Am J Pathol 166(2):491-497
72. Li F, Zhang C et al (2005) ANG II-induced neointimal growth is mediated via cPLA2- and PLD2-activated Akt in balloon-injured rat carotid artery. Am J Physiol Heart Circ Physiol 289(6): H2592-H2601
73. Ma K, Mallidis C et al (2001) Characterization of 50-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am J Physiol Endocrinol Metab 281(6):E1128-E1136
74. Machida S, Spangenburg EE et al (2003) Forkhead transcription factor FoxO1 transduces insulin-like growth factor's signal to p27Kip1 in primary skeletal muscle satellite cells. J Cell Physiol 196(3):523-531
75. Massague J, Chen YG (2000) Controlling TGF-beta signaling. Genes Dev 14(6):627-644
76. Mauro A (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9:493-495
77. McCarthy JJ, Esser KA et al (2007) MicroRNA-206 is overexpressed in the diaphragm but not the hindlimb muscle of mdx mouse. Am J Physiol Cell Physiol 293(1):C451-C457
78. McCroskery S, Thomas M et al (2003) Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 162(6):1135-1147
79. McCroskery S, Thomas M et al (2005) Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin- null mice. J Cell Sci 118(Pt 15):3531-3541
80. McElhinny AS, Kakinuma K et al (2002) Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1. J Cell Biol 157(1):125-136
81. McGeachie JK, Grounds MD (1987) Initiation and duration of muscle precursor replication after mild and severe injury to skeletal muscle of mice. An autoradiographic study. Cell Tissue Res 248(1):125-130
82. McPherron AC, Lawler AM et al (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387(6628):83-90
83. McPherron AC, Lee SJ (2002) Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109(5):595-601
84. Minetti GC, Colussi C et al (2006) Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med 12(10):1147-1150
85. Miro O, Pedrol E et al (1997) Skeletal muscle studies in patients with HIV-related wasting syndrome. J Neurol Sci 150(2):153-159
86. Mitch WE, Price SR (2001) Transcription factors and muscle cachexia: is there a therapeutic target? Lancet 357(9258):734-735
87. Motta MC, Divecha N et al (2004) Mammalian SIRT1 represses forkhead transcription factors. Cell 116(4):551-563
88. Musaro A, McCullagh K et al (2001) Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27(2):195-200
89. Nakamura T, Takio K et al (1990) Activin-binding protein from rat ovary is follistatin. Science 247(4944):836-838
90. Nowak KJ, Davies KE (2004) Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. EMBO Rep 5(9):872-876
91. O'Rourke JR, Georges SA et al (2007) Essential role for Dicer during skeletal muscle development. Dev Biol 311(2):359-368
92. Phelan JN, Gonyea WJ (1997) Effect of radiation on satellite cell activity and protein expression in overloaded mammalian skeletal muscle. Anat Rec 247(2):179-188
93. Price DA, Bassendine MF et al (2006) Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection. Gut 55(5):715-718
94. Putman CT, Dusterhoft S et al (1999) Changes in satellite cell content and myosin isoforms in low-frequency-stimulated fast muscle of hypothyroid rat. J Appl Physiol 86(1):40-51
95. Reimann J, Brimah K et al (2004) Pax7 distribution in human skeletal muscle biopsies and myogenic tissue cultures. Cell Tissue Res 315(2):233-242
96. Reisz-Porszasz S, Bhasin S et al (2003) Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am J Physiol Endocrinol Metab 285(4):E876-E888
97. Rios R, Carneiro I et al (2002) Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol 282(5):C993-C999
98. Roberts SB, Goetz FW (2001) Differential skeletal muscle expression of myostatin across teleost species, and the isolation of multiple myostatin isoforms. FEBS Lett 491(3):212-216
99. Rosenblatt JD, Yong D et al (1994) Satellite cell activity is required for hypertrophy of overloaded adult rat muscle. Muscle Nerve 17(6):608-613
100. Rudnicki MA, Le Grand F et al (2008) The molecular regulation of muscle stem cell function. Cold Spring Harb Symp Quant Biol 73:323-331
101. Sacheck JM, Ohtsuka A et al (2004) IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophyrelated ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 287(4):E591-E601
102. Saitoh M, Pullen N et al (2002) Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site. J Biol Chem 277(22):20104-20112
103. Salerno MS, Thomas M et al (2004) Molecular analysis of fiber typespecific expression of murine myostatin promoter. Am J Physiol Cell Physiol 287(4):C1031-C1040
104. Sampaolesi M, Torrente Y et al (2003) Cell therapy of alphasarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301(5632):487-492
105. Sampaolesi M, Biressi S et al (2005) Cell therapy of primary myopathies. Arch Ital Biol 143(3-4):235-242
106. Sampaolesi M, Blot S et al (2006) Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444(7119):574-579
107. Sandri M (2008) Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 23:160-170
108. Sandri M, Sandri C et al (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117(3):399-412
109. Sartorelli V, Fulco M (2004) Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy. Sci STKE 2004(244):re11
110. Schakman O, Gilson H et al (2008) Mechanisms of glucocorticoidinduced myopathy. J Endocrinol 197(1):1-10
111. Schiaffino S, Sandri M et al (2007) Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology (Bethesda) 22:269-278
112. Schuelke M, Wagner KR et al (2004) Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350(26):2682-2688
113. Secrist JP, Zhou X et al (2003) HDAC inhibitors for the treatment of cancer. Curr Opin Investig Drugs 4(12):1422-1427
114. Seuntjens E, Umans L et al (2009) Transforming Growth Factor type beta and Smad family signaling in stem cell function. Cytokine Growth Factor Rev
115. Sever JL, Rakusan TA et al (1996) HIV antibody responses in children of HIV-infected mothers. Pediatr AIDS HIV Infect 7(4):246-253
116. Sherwood RI, Christensen JL et al (2004) Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell 119(4):543-554
117. Singh JP, Larson MG et al (2001) Genetic factors contribute to the variance in frequency domain measures of heart rate variability. Auton Neurosci 90(1-2):122-126
118. Southgate RJ, Bruce CR et al (2005) PGC-1alpha gene expression is down-regulated by Akt- mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle. Faseb J 19(14):2072-2074
119. Southgate RJ, Neill B et al (2007) FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle. J Biol Chem 282(29):21176-21186
120. Spiller MP, Kambadur R et al (2002) The myostatin gene is a downstream target gene of basic helix-loop-helix transcription factor MyoD. Mol Cell Biol 22(20):7066-7082
121. Stark A, Brennecke J et al (2005) Animal MicroRNAs confer robustness to gene expression and have a significant impact on 30UTR evolution. Cell 123(6):1133-1146
122. Stitt TN, Drujan D et al (2004) The IGF-1/PI3 K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14(3):395-403
123. Suzuki N, Motohashi N et al (2007) NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J Clin Invest 117(9):2468-2476
124. Tran H, Brunet A et al (2003) The many forks in FOXO's road. Sci STKE 2003(172):RE5
125. Voisin L, Gray K et al (1996) Altered expression of eukaryotic initiation factor 2B in skeletal muscle during sepsis. Am J Physiol 270(1 Pt 1):E43-E50
126. Wagner KR, McPherron AC et al (2002) Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol 52(6):832-836
127. Wagner KR, Liu X et al (2005) Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci USA 102(7):2519-2524
128. Wehling M, Cai B et al (2000) Modulation of myostatin expression during modified muscle use. Faseb J 14(1):103-110
129. Whalen RG, Harris JB et al (1990) Expression of myosin isoforms during notexin-induced regeneration of rat soleus muscles. Dev Biol 141(1):24-40
130. Yang ZZ, Tschopp O et al (2004) Physiological functions of protein kinase B/Akt. Biochem Soc Trans 32(Pt 2):350-354
131. Zammit P, Beauchamp J (2001) The skeletal muscle satellite cell: stem cell or son of stem cell? Differentiation 68(4-5):193-204
132. Zammit PS, Relaix F et al (2006) Pax7 and myogenic progression in skeletal muscle satellite cells. J Cell Sci 119(Pt 9):1824-1832
133. Zhu X, Topouzis S et al (2004) Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine 26(6):262-272